Fully Automated Immunoassays

Add Efficiency to Your Workflow with BioPlex 2200 System
The BioPlex 2200 System is a fully automated, random access multiplex system that allows for simultaneous detection of multiple analytes in one single test to maximize your virology testing workflow.
The BioPlex 2200 System, a fully-automated, random access, multiplex testing platform, uses sets of coated magnetic beads as the basis for virology screening.
Automated EIAs

Fully Automated and Truly Open EIA System
Designed for low to high volume testing, the EVOLIS System is fully automated for walkaway operation.

Human Immunodeficiency Virus (HIV)
Browse our EIA kits for detecting HIV p24 antigen and antibodies to HIV-1 and HIV-2. We also have solutions for detection of antibodies to HIV-1 and HIV-2.

Hepatitis B (HBV)
Explore assays for blood screening and diagnostic testing for Hepatitis B, including detection of both surface antigen and antibody, as well as nucleocapsid core antibody.

Hepatitis C (HCV)
Obtain excellent sensitivity, specificity, and breadth of hepatitis C virus (HCV) detection with our microplate-based HCV test.

TORCH
Use our tests for the diagnosis and monitoring of prenatal and congenital infections: Toxoplasma gondii, rubella virus, cytomegalovirus, or herpes simplex virus.

Epstein Barr Virus (EBV)
Explore complete microplate EIA kits for the detection of specific IgM and IgG antibodies to EBV antigens, aiding in determination of the stage of the EBV infection.

Hepatitis A (HAV)
Introduce reliable enzyme immunoassays that can aid in the diagnosis of HAV infection based on detection of antibodies to HAV.

SARS-CoV-2
Reliably detect anti-SARS-CoV-2 IgM, IgA and IgG in one convenient and fast test to determine the immune response to SARS-CoV-2.

Vaccine Preventable Diseases
Explore our EIA kits to assess for immunity against measles, mumps, rubella or varicella-zoster virus.
Automated Immunoassays (EIAs)

Fully Automated and Truly Open EIA System
To screen blood for viruses and other blood-borne pathogens, Bio-Rad provides microplate and other immunoassay reagents for retrovirus, hepatitis viruses and other infectious agent testing.

Sexually Transmitted Diseases
Find the reagents you need for donor screening and for diagnostic testing.
• Human immunodeficiency Virus (HIV)
• Hepatitis B (HBV)
• Hepatitis C (HCV)

Tropical Diseases
For detection of Dengue Antigen NS1.
• Dengue (Without Brucellosis, Leishmaniasis)

Vaccine Preventable Diseases
Comprehensive menu of immunoassays for the detection of IgM and IgG antibodies to measles virus, mumps virus, rubella virus and varicella-zoster virus.
• Mumps virus
• Measles virus
• Rubella virus
• Varicella-zoster virus (VZV)

Prenatal and Congenital Diseases
Comprehensive menu of immunoassays for detection and monitoring infections with Toxoplasma gondii, Rubella, Cytomegalovirus, or Herpes Simplex Virus.
• Rubella virus
• Cytomegalovirus (CMV)
• Herpes simplex virus (HSV)

Respiratory Diseases
Assays for the detection of antibodies to SARS-CoV-2 and quantification of S IgG to SARS-CoV-2.
• SARS-CoV-2

Infectious Mononucleosis
Comprehensive menu of immunoassays for the detection of IgM and IgG antibodies to Epstein-Barr Virus.
• Epstein-Barr Virus
Confirmatory Testing

Geenius™ Solution
A complete system for HIV-1 and HIV-2 antibody confirmation and differentiation in serum, plasma, or whole blood (venous and fingerstick), providing automated reading and interpretation of the results.

Geenius Solution
Confirming HIV and HCV antibodies has never been simpler. The Geenius™ Solution let you confirm results from HIV or HCV screening tests all on one instrument in less than 30 minutes.

Geenius HIV Supplemental Assay for Diagnostic Testing
Take HIV testing to the next level with a more specific test to confirm the presence of antibodies to HIV-1/HIV-2.

Geenius HIV Supplemental Assay for Donor Testing
Supplement HIV testing with a more specific test for human serum and plasma samples with repeatedly reactive results by an FDA licensed blood donor screening test for antibodies to HIV-1/HIV-2.

The Geenius HIV 1/2 Supplemental Assay is intended for use as an aid in the diagnosis of infection with HIV-1 and/or HIV-2. It is also intended for the confirmation and differentiation of individual antibodies to HIV-1 and HIV-2 in serum/plasma samples from blood donors.

Rapid HIV-1 and HIV-2 Confirmation and Differentiation
The Geenius HIV 1/2 Confirmatory Assay confirms and differentiates antibodies to HIV-1 and HIV-2 in serum, plasma, venous and fingerstick whole blood samples.

Rapid HCV Confirmation
The Geenius HCV Supplemental Assay confirms the presence of anti-HCV antibodies in venous whole blood, serum, and plasma samples.
Unitary Rapid Testing

Genie Fast HIV 1/2 Assay
Rapid test for the specific detection of anti-HIV-1 and anti-HIV-2 antibodies in human serum, plasma and whole blood.

SARS-CoV-2
Quickly and effectively detect and isolate positive SARS-CoV-2 and its prominent variant cases in 15 minutes.
Access Automated Immunoassays

Diagnosing HIV and HCV
Bio-Rad has developed high performance immunoassays for the diagnosis of the Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) on Beckman Coulter Access family of immunoassay systems.
Those products are distributed by Beckman Coulter ; for further information, please contact the Beckman Coulter office nearest you.